Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/23/2010US7683052 Crystalline polymorph of bazedoxifene acetate
03/23/2010US7683051 Crystalline polymorph of bazedoxifene acetate
03/23/2010US7683050 Anticancer agents; parasiticides, viricides, fungicides, bactericides; sealed container consisting of an aqueous solution of homoharringtonine (4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl) (HHT), wherein solution is free of pharmaceutical excipients and said sealed container is an ampule or vial
03/23/2010US7683049 beta -methyl carbapenem compounds; for multiple-drug resistant bacterial strain
03/23/2010US7683048 crystal form of 3-methylthiophene-2-carboxylic acid (6S,9R,10S,11S,13S,16R, 17R)-9-chloro-6-fluoro-11-hydroxy-17-methoxycarbonyl-10,13,16-trimethyl-3-oxo-6,7,8,9,10, 11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester; asthma, chronic obstructive pulmonary disease; dermatitis
03/23/2010US7683047 Treatment of conditions relating to hormone deficiencies by administration of progestins
03/23/2010US7683046 Autoimmune diseasesl; antiinflammatory agents; anticancer agents; benzodiazepine compound
03/23/2010US7683045 Class of γδ T cells activators and use thereof
03/23/2010US7683043 Creatine phosphate analog prodrugs, compositions and uses thereof
03/23/2010US7683042 stabilized glucosamine base composition having a purity level of at least 99.0 wt. % and a maximum halide content of about 0.01 wt. % coated with at least one pharmaceutically acceptable polymer comprising a water-soluble, water-immiscible and/or water-swellable homopolymer
03/23/2010US7683041 Microgel particles for the delivery of bioactive materials
03/23/2010US7683040 Intranasal formulation of rotigotine
03/23/2010US7683039 Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
03/23/2010US7683038 Such as gellan, carboxymethylcellulose, pectic acid, pectin and hyaluronic acid derivativesl; for use in the pharmaceutical, biomedical, surgical and healthcare fields
03/23/2010US7683037 Myocardial perfusion imaging method
03/23/2010US7683036 especially nucleic acid and nucleic acid-like oligomers, which are targeted to or mimic nucleic acids comprising or encoding small non-coding RNAs, and which act to modulate the levels of small non-coding RNAs, or interfere with their function
03/23/2010US7683035 Method of stabilizing and/or isolating nucleic acids
03/23/2010US7683034 Use of enzyme inhibitors of aminopeptidase N and/or dipeptidylpeptidase IV
03/23/2010US7682787 Using UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T3) to identify modulators for prevention and treatment of familial tumoral calcinosis (FTC)
03/23/2010US7682638 Use of hederagenin 3-O-α-L-rhamnopyranosyl(1-2)-[β-D-glucopyranosyl(1-4)]-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
03/23/2010US7682637 Efficient method for producing compositions enriched in total phenols
03/23/2010US7682636 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
03/23/2010US7682632 Tamper-resistant oral opioid agonist formulations
03/23/2010US7682628 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
03/23/2010US7682627 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
03/23/2010US7682626 Polyvinylethers for delivery of polynucleotides to mammalian cells
03/23/2010US7682625 Comprising hydrolyzed gelatin/tryptophan and ingestible carrier; for decubitus ulcers/bariatric surgery
03/23/2010US7682624 Method for treating wounds to promote healing
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010US7682614 blocking or reducing airway hyperresponsiveness using beta -galactosylceramide or anti-CD1d antibody; systemic lupus erythematosus (SLE), cancer, atherosclerosis, and allergic disease
03/23/2010US7682612 Chronic Lymphocytic Leukemia (CLL) is treated with antibodies directed against the CD20 antigen; rituximab; chemotherapy
03/23/2010US7682606 Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates
03/23/2010US7682491 Adding antifouling agents based on a polyolefin of one or more C2-C10 monomers having a C4-C10 monounsaturated dicarboxylic acid end group; polyisobutylene succinic anhydride; low dosage; used especially for ethylene dichloride distillation units, polychloroprene containing ferric ions; solvent mixtures
03/23/2010US7682387 Drug-delivery endovascular stent and method for treating restenosis
03/23/2010CA2610821C Organic salts of .beta.-alanine
03/23/2010CA2607237C The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
03/23/2010CA2582906C Use of a container of an inorganic additive containing plastic material
03/23/2010CA2555741C Method of stimulating hair growth
03/23/2010CA2524074C Oral composition to reduce cold symptoms and duration of same
03/23/2010CA2519801C Use of 5-substituted nucleosides
03/23/2010CA2500485C Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
03/23/2010CA2499138C Conjugated linoleic acid compositions
03/23/2010CA2487377C Mycophenolate mofetil in diabetic nephropathy
03/23/2010CA2471729C Prucalopride-n-oxide
03/23/2010CA2465686C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/23/2010CA2459928C Photodynamic porphyrin antimicrobial agents
03/23/2010CA2446059C Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
03/23/2010CA2437563C Photodynamic therapy of occult age-related macular degeneration
03/23/2010CA2421240C Granular preparations for oral administration
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2406533C 3-methoxybenzyl thiourea derivatives and lipid composition containing same
03/23/2010CA2404278C Naphthalimide compositions and uses thereof
03/23/2010CA2401000C Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
03/23/2010CA2399405C 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
03/23/2010CA2397594C Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
03/23/2010CA2396702C N,o-amidomalonate platinum complexes
03/23/2010CA2392709C Polyhydroxylated aromatic compounds for the treatment of amyloidosis
03/23/2010CA2390317C Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
03/23/2010CA2389928C Method for treating diabetes
03/23/2010CA2389767C Quinazoline derivatives as vegf inhibitors
03/23/2010CA2389745C Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
03/23/2010CA2380951C Pharmaceutical compositions for oral and topical administration
03/23/2010CA2378052C Use of ginkgo extract
03/23/2010CA2377783C Epitopes formed by non-covalent association of conjugates
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2372994C Implantable gel compositions and method of manufacture
03/23/2010CA2364742C Anthelmintic composition
03/23/2010CA2358457C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
03/23/2010CA2356680C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
03/23/2010CA2352436C Polymorphs of telmisartan, processes for preparing them and their use in the preparation of a pharmaceutical composition
03/23/2010CA2346869C Phospholipid derivatives of non-steroidal anti-inflammatory drugs
03/23/2010CA2332608C Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
03/23/2010CA2332488C Cells and animals deficient in protein kinase c epsilon
03/23/2010CA2311755C Therapeutic formulation for administering tolterodine with controlled release
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2283535C Glycine transporter
03/23/2010CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
03/23/2010CA2209124C Antitumor agent effect enhancer containing il-6 antagonist
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2196656C Method for the preparation of (±)-calanolide a and intermediates thereof
03/23/2010CA2194797C Nucleic acid containing composition, preparation and uses of same
03/23/2010CA2149818C Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
03/18/2010WO2010031061A1 Methods of treatment of hyperuricemia and associated disease states
03/18/2010WO2010031056A2 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010WO2010031051A1 Methods of treatment of hyperuricemia and associated disease states
03/18/2010WO2010031043A2 Reducing or preventing neuroinflammation or neurotoxicity
03/18/2010WO2010030997A1 Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
03/18/2010WO2010030995A2 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
03/18/2010WO2010030988A1 Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
03/18/2010WO2010030983A2 Pyrazole carboxamide inhibitors of factor xa
03/18/2010WO2010030976A2 Methods and compositions for inhibiting atherosclerosis and vascular inflammation
03/18/2010WO2010030967A1 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/2010WO2010030954A1 Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
03/18/2010WO2010030948A2 Hedgehog signaling and cancer stem cells in hematopoietic cell malignancies
03/18/2010WO2010030931A1 Oligonucleotides targeting human endogenous retrovirus 9 (erv-9) long terminal repeat (ltr) and methods of use
03/18/2010WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods
03/18/2010WO2010030887A1 Nicotinic attenuation of cns inflammation and autoimmunity
03/18/2010WO2010030868A1 Solvent extraction microencapsulation with tunable extraction rates
03/18/2010WO2010030851A1 ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP
1 ... 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 ... 7860